Deprecated: Use of MediaWiki\Output\OutputPage::setIndexPolicy with index after noindex was deprecated in MediaWiki 1.43. [Called from MediaWiki\Output\OutputPage::setRobotPolicy in /home/forge/wikitrademarks.org/includes/Output/OutputPage.php at line 1008] in /home/forge/wikitrademarks.org/includes/debug/MWDebug.php on line 385
Category:Abigail Liebow of Somerville MA (US) - WikiTrademarks Jump to content

Category:Abigail Liebow of Somerville MA (US)

From WikiTrademarks
Revision as of 06:01, 30 March 2025 by Unknown user (talk) (Updating Category:Abigail_Liebow_of_Somerville_MA_(US))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Abigail Liebow of Somerville MA (US)

Executive Summary

Abigail Liebow of Somerville MA (US) is an inventor who has filed 3 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (3 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (2 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (2 patents), and they have worked with companies such as Alnylam Pharmaceuticals, Inc. (3 patents). Their most frequent collaborators include (3 collaborations), (2 collaborations), (2 collaborations).

Patent Filing Activity

File:Abigail Liebow of Somerville MA (US) Monthly Patent Applications.png

Technology Areas

File:Abigail Liebow of Somerville MA (US) Top Technology Areas.png

List of Technology Areas

  • C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 3 patents
  • A61K31/713 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
  • C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
  • C12N2310/315 (of the backbone): 2 patents
  • C12N2310/3515 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
  • C12N2310/321 (2'-O-R Modification): 2 patents
  • A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
  • A61K47/549 ({Sugars, nucleosides, nucleotides or nucleic acids}): 1 patents
  • C12N15/1137 ({against enzymes (viral enzymes): 1 patents
  • A61K31/00 (Medicinal preparations containing organic active ingredients): 1 patents
  • A61K45/00 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • C12N2310/344 (Spatial arrangement of the modifications): 1 patents
  • C12N2310/346 (Spatial arrangement of the modifications): 1 patents
  • C12N2310/351 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12Y101/03015 (ENZYMES): 1 patents
  • A61K31/7105 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12N2310/3125 (of the backbone): 1 patents
  • C12N2310/313 (of the backbone): 1 patents
  • C12N2310/3231 (modified ring structure): 1 patents
  • C12N2310/3521 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12N2310/3523 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12N2310/3525 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12Y101/01027 (ENZYMES): 1 patents
  • A61P1/16 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P1/18 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P3/04 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P3/06 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P3/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P9/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P9/12 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P13/12 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P15/08 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P43/00 (Drugs for specific purposes, not provided for in groups): 1 patents
  • C12N2310/322 (2'-R Modification): 1 patents
  • C12N2310/335 (of the base): 1 patents
  • C12N2310/343 (Spatial arrangement of the modifications): 1 patents

Companies

File:Abigail Liebow of Somerville MA (US) Top Companies.png

List of Companies

  • Alnylam Pharmaceuticals, Inc.: 3 patents

Collaborators

Subcategories

This category has the following 9 subcategories, out of 9 total.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.